StocksFin Logo
AMPH logo
$AMPH

Amphastar Pharmaceuticals, Inc.

AMPH country of incorporation
|
https://www.amphastar.com
|
Dr. Jack Zhang
|
1,761 employees
NASDAQ | Healthcare | Drug Manufacturers—Specialty & Generic
AMPH reported its Q322 earnings on November 8, 2022 (105 weeks ago).
$120.13M 7.1% vs. Q321 Revenues Q322
48.71% 6.8% vs. Q321 Gross Profit Margin
13.21% -49.8% vs. Q321 Net Profit Margin
14.75M 417.2% vs. Q321 Free Cash Flow Q322
$0.32 -48.4% vs. Q321 EPS Q322
Company Card Q322
As reported on November 8, 2022
Is profitable?
Has Revenue Growth?
Has Net Profit Growth?
Has FCF Growth?
Has OCF Growth?
Has EPS Growth?
Pays a Dividend?
Rating
B
Growth calculated YoY
Company Card Q322
As reported on November 8, 2022
Is profitable?
Has Revenue Growth?
Has Net Profit Growth?
Has FCF Growth?
Has OCF Growth?
Has EPS Growth?
Pays a Dividend?
Rating
B
Growth calculated YoY
Overview
Income Statement
Full Income Statement
Period Net Revenue Cost of Revenue Net Profit EPS
FY2022 Not reported yet.
Q32022
120.13M
-2.7%
61.62M
15.87M
-8.5%
$0.32
Q22022
123.47M
+2.6%
60.11M
17.35M
-28.5%
$0.35
Q12022
120.37M
64.54M
24.25M
$0.5
FY2021
437.77M
 238.03M
63.3M
$1.35
Q42021
120.89M
+7.7%
64.65M
19.76M
-33.1%
$0.41
Q32021
112.2M
+10.4%
61.02M
29.55M
+280.4%
$0.62
Q22021
101.66M
-1.3%
54.29M
7.77M
+54.1%
$0.16
Q12021
103.02M
58.07M
5.04M
$0.11
FY2020
349.85M
 206.51M
1.4M
$0.03
FY2019
322.36M
 190.43M
48.94M
$1.04
FY2018
294.67M
 187.68M
-5.74M
$-0.12
Balance Sheet
Full Balance Sheet
Period Total Assets Total Liabilities Cash & Eq. Debt Stock Equity
FY2022 Not reported yet.
Q32022
726.7M
 221.53M
157.24M
103.24M
505.17M
Q22022
723.72M
 224.41M
166.16M
103.92M
499.31M
Q12022
716.24M
 236.71M
172.63M
105.28M
479.53M
FY2021
671.53M
 226.01M
126.35M
109.85M
445.52M
FY2020
631.24M
 182.51M
92.64M
65.43M
402.31M
FY2019
586.97M
 159.44M
73.69M
61.23M
381.37M
FY2018
513.56M
 149.2M
86.34M
68.44M
332.44M
Cash Flow Statement
Full Cash Flow Statement
Period Operating CF Investing CF Financing CF Capex Free Cash Flow
FY2022 Not reported yet.
Q32022
20.38M
 -15.26M
-13.93M
-5.62M
14.75M
+568.8%
Q22022
2.82M
 -8.18M
-994k
-5.96M
-3.15M
-107.1%
Q12022
50.77M
 -9.11M
4.65M
-6.14M
44.63M
FY2021
0
 0
0
0
0
FY2020
57.27M
 -36.42M
-2.25M
-33.86M
23.41M
FY2019
41.76M
 -50.53M
-3.78M
-41.56M
207k
FY2018
38.19M
 -42.18M
25.01M
-46.81M
-8.62M
Institutional Ownership
Dividend History
No dividend history.
Number of Employees